153 related articles for article (PubMed ID: 31671381)
21. Germline variants in pancreatic cancer patients with a personal or family history of cancer fulfilling the revised Bethesda guidelines.
Ohmoto A; Morizane C; Kubo E; Takai E; Hosoi H; Sakamoto Y; Kondo S; Ueno H; Shimada K; Yachida S; Okusaka T
J Gastroenterol; 2018 Oct; 53(10):1159-1167. PubMed ID: 29667044
[TBL] [Abstract][Full Text] [Related]
22. Having pancreatic cancer with tumoral loss of ATM and normal TP53 protein expression is associated with a poorer prognosis.
Kim H; Saka B; Knight S; Borges M; Childs E; Klein A; Wolfgang C; Herman J; Adsay VN; Hruban RH; Goggins M
Clin Cancer Res; 2014 Apr; 20(7):1865-72. PubMed ID: 24486587
[TBL] [Abstract][Full Text] [Related]
23. Copy-number variants in patients with a strong family history of pancreatic cancer.
Lucito R; Suresh S; Walter K; Pandey A; Lakshmi B; Krasnitz A; Sebat J; Wigler M; Klein AP; Brune K; Palmisano E; Maitra A; Goggins M; Hruban RH
Cancer Biol Ther; 2007 Oct; 6(10):1592-9. PubMed ID: 17912030
[TBL] [Abstract][Full Text] [Related]
24. Familial pancreatic carcinoma in Jews.
Lynch HT; Deters CA; Lynch JF; Brand RE
Fam Cancer; 2004; 3(3-4):233-40. PubMed ID: 15516847
[TBL] [Abstract][Full Text] [Related]
25. Characterization of a germline variant TNS1 c.2999-1G > C in a hereditary cancer syndrome family.
Di X; Wang D; Wu J; Zhu X; Wang Y; Yan J; Wen L; Jiang H; Wen D; Shu B; Zhang S
Gene; 2024 May; 908():148304. PubMed ID: 38387708
[TBL] [Abstract][Full Text] [Related]
26. [Hereditary gastric and pancreatic cancer predisposition syndromes].
Leoz ML; Sánchez A; Carballal S; Ruano L; Ocaña T; Pellisé M; Castells A; Balaguer F; Moreira L
Gastroenterol Hepatol; 2016; 39(7):481-93. PubMed ID: 26916701
[TBL] [Abstract][Full Text] [Related]
27. A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.
Buys SS; Sandbach JF; Gammon A; Patel G; Kidd J; Brown KL; Sharma L; Saam J; Lancaster J; Daly MB
Cancer; 2017 May; 123(10):1721-1730. PubMed ID: 28085182
[TBL] [Abstract][Full Text] [Related]
28. Ataxia-telangiectasia gene (
Jerzak KJ; Mancuso T; Eisen A
Curr Oncol; 2018 Apr; 25(2):e176-e180. PubMed ID: 29719442
[TBL] [Abstract][Full Text] [Related]
29. A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants.
Earl J; Galindo-Pumariño C; Encinas J; Barreto E; Castillo ME; Pachón V; Ferreiro R; Rodríguez-Garrote M; González-Martínez S; Ramon Y Cajal T; Diaz LR; Chirivella-Gonzalez I; Rodriguez M; de Castro EM; García-Seisdedos D; Muñoz G; Rosa JMR; Marquez M; Malats N; Carrato A
EBioMedicine; 2020 Mar; 53():102675. PubMed ID: 32113160
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of deleterious ATM germline mutations in gastric cancer patients.
Huang DS; Tao HQ; He XJ; Long M; Yu S; Xia YJ; Wei Z; Xiong Z; Jones S; He Y; Yan H; Wang X
Oncotarget; 2015 Dec; 6(38):40953-8. PubMed ID: 26506520
[TBL] [Abstract][Full Text] [Related]
31. Hereditary pancreatic cancer: a clinical perspective.
Greer JB; Lynch HT; Brand RE
Best Pract Res Clin Gastroenterol; 2009; 23(2):159-70. PubMed ID: 19414143
[TBL] [Abstract][Full Text] [Related]
32. Frequency of the ATM IVS10-6T-->G variant in Australian multiple-case breast cancer families.
Lindeman GJ; Hiew M; Visvader JE; Leary J; Field M; Gaff CL; Gardner RJ; Trainor K; Cheetham G; Suthers G; Kirk J
Breast Cancer Res; 2004; 6(4):R401-7. PubMed ID: 15217508
[TBL] [Abstract][Full Text] [Related]
33. Evidence for a major gene influencing risk of pancreatic cancer.
Klein AP; Beaty TH; Bailey-Wilson JE; Brune KA; Hruban RH; Petersen GM
Genet Epidemiol; 2002 Aug; 23(2):133-49. PubMed ID: 12214307
[TBL] [Abstract][Full Text] [Related]
34. Genetic predisposition to pancreatic cancer.
Ghiorzo P
World J Gastroenterol; 2014 Aug; 20(31):10778-89. PubMed ID: 25152581
[TBL] [Abstract][Full Text] [Related]
35. Ataxia-telangiectasia locus: sequence analysis of 184 kb of human genomic DNA containing the entire ATM gene.
Platzer M; Rotman G; Bauer D; Uziel T; Savitsky K; Bar-Shira A; Gilad S; Shiloh Y; Rosenthal A
Genome Res; 1997 Jun; 7(6):592-605. PubMed ID: 9199932
[TBL] [Abstract][Full Text] [Related]
36. The Perils of Single-Site Genetic Testing for Hereditary Cancer Syndromes in the Era of Next-Generation Sequencing.
Casasanta N; Stark E; McHenry A; Biagi T; Kaltman R
Oncologist; 2018 Apr; 23(4):393-396. PubMed ID: 29445031
[TBL] [Abstract][Full Text] [Related]
37. Familial pancreatic cancer.
Klein AP; Hruban RH; Brune KA; Petersen GM; Goggins M
Cancer J; 2001; 7(4):266-73. PubMed ID: 11561603
[TBL] [Abstract][Full Text] [Related]
38.
Nanda N; Roberts NJ
Genes (Basel); 2020 Jan; 11(1):. PubMed ID: 31963441
[TBL] [Abstract][Full Text] [Related]
39. Cryptic deletion involving the ATM locus at 11q22.3 approximately q23.1 in B-cell chronic lymphocytic leukemia and related disorders.
Eclache V; Caulet-Maugendre S; Poirel HA; Djemai M; Robert J; Lejeune F; Raphaël M
Cancer Genet Cytogenet; 2004 Jul; 152(1):72-6. PubMed ID: 15193446
[TBL] [Abstract][Full Text] [Related]
40. Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATM.
Laake K; Odegård A; Andersen TI; Bukholm IK; Kåresen R; Nesland JM; Ottestad L; Shiloh Y; Børresen-Dale AL
Genes Chromosomes Cancer; 1997 Mar; 18(3):175-80. PubMed ID: 9071570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
